Dry Powder is a Ticking Clock.

Private Equity is currently sitting on an estimated **$2.2 trillion** in global dry powder, with over $1 trillion concentrated in the U.S. middle market. But capital isn't just sitting; it is aging. After two years of subdued dealmaking, General Partners (GPs) are facing intense pressure from their Limited Partners (LPs) to generate liquidity. We are entering a "Seller's Window" where buyers are finally willing to pay premiums for institutionally-ready firms to clear their deployment backlog.

The Funding Delta

The cost of financing has finally broken the 2024 peak. In Q1 2026, the average funding cost for a middle-market term loan has dropped by **300 basis points**. This shift has fundamentally changed the LBO math. A company that was valued at 8.5x last year is now commandingly clearing 11x, simply because the cost of the leverage used to buy it has normalized. If you are still waiting for "better rates," you are missing the crest of the wave.

The "Second Bite" Advantage

A 100% cash exit is often the least efficient way to leave your legacy. In the Q1 2026 market, "Rollover Equity" has moved from a negotiation filler to a core strategy. By retaining 25%–30% of your equity in the acquiring PE platform, you are essentially "selling twice." You capture a lucrative cash payout today, while your remaining stake grows alongside the PE firm's capital and AI-driven operational playbooks. This 'second bite' often exceeds the value of the first sale.

Executive Verdict

Timing isn't just about the calendar; it's about the math of the buyer. With financing costs down and dry powder reaching its expiration date, the Q2 2026 window represents a structural sweet spot for middle-market founders. However, the premium multiples are reserved for firms that can prove "System Immaturity" has been solved with AI-augmented workflows. If you haven't architected your exit chassis, you are volunteering for a 40% discount.